Home > Food & Beverages > Nutraceuticals > Amino Acids > Branched Chain Amino Acids (BCAAs) Market

Branched Chain Amino Acids (BCAAs) Market Share

Report ID: GMI7051
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Branched Chain Amino Acids (BCAAs) Market Share

Some of the major companies operating in the Branched chain amino acids (BCAAs) industry are:

Ajinomoto
Kyowa Hakko Bio
Evonik
BASF
Toray Industries
DSM
Kerry Group
Glanbia
Archer Daniels Midland (ADM)
Cargill.

These companies focus on strategic partnerships, new type launch & commercialization for market expansion. Furthermore, these companies are heavily investing in research that allows them to introduce innovative types and garner maximum revenue in the market.

Authors: Kunal Ahuja, Manish Mohanan, Himanshu Kabra

Frequently Asked Questions (FAQ) :

Branched chain amino acids (BCAAs) market was valued at around USD 1,450.1 million in 2022 and is estimated to reach USD 2,608.3 million by the end of 2032, as the product has gained popularity as dietary supplements among athletes, bodybuilders, and fitness enthusiasts.

L-Leucine held a majority market value of USD 652.7 million in 2022 as it is known for stimulating muscle protein synthesis as well as initiating the process of muscle repair and growth.

North America BCAAs market was worth USD 507.3 million in 2022 and is anticipated to expand at a significant pace from 2023-2032 as the region has a strong health and fitness culture with a significant number of individuals actively engaged in sports, fitness, and bodybuilding.

Ajinomoto, Kyowa Hakko Bio, Evonik, BASF, Toray Industries, DSM, Kerry Group, Glanbia, Archer Daniels Midland (ADM), and Cargill.